References
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T (1978) Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 187: 1–7
Giedraitis V, He B, Huang WX, Hillert J (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112: 146–152
Kliegman RM, Fanaroff AA (1984) Necrotizing enterocolitis. N Engl J Med 310: 1093–1103
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12: 53–72
Pages F, Berger A, Lebel-Binay S, Zinzindohoue F, Danel C, Piqueras B, Carriere O, Thiounn N, Cugnenc PH, Fridman WH (2000) Proinflammatory and antitumor properties of interleukin-18 in the gastrointestinaltract. Immunol Lett 75: 9–14
Szalai C, Czinner A, Revai K (1996) The frequency of medium chain acyl-CoA dehydrogenase G985 mutation in Hungary. Eur J Pediatr 155: 256
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Héninger, E., Treszl, A., Kocsis, I. et al. Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161, 410–411 (2002). https://doi.org/10.1007/s00431-002-0968-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-002-0968-y